Bal Pharma Ltd Quarterly Result
Bal Pharma Ltd
NSE: BALPHARMA
Net Profit - Last Quarter
Bal Pharma Ltd Quarterly Results Key Highlights
- The revenue of Bal Pharma Ltd for the Mar '26 is ₹ 83.84 crore as compare to the Dec '25 revenue of ₹ 88.02 crore.
- This represent the decline of -4.75% The ebitda of Bal Pharma Ltd for the Mar '26 is ₹ 10.33 crore as compare to the Dec '25 ebitda of ₹ 9.87 crore.
- This represent the growth of 4.66% The net profit of Bal Pharma Ltd for the Mar '26 is ₹ 3.6 crore as compare to the Dec '25 net profit of ₹ 1.79 crore.
- This represent the growth of 101.12%.
Bal Pharma Ltd Quarterly Results Analysis
Market Price of Bal Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 29 Jul 2026 | 88.14 |
| 28 Jul 2026 | 87.11 |
| 27 Jul 2026 | 89.24 |
| 24 Jul 2026 | 87.08 |
| 23 Jul 2026 | 88.21 |
| 22 Jul 2026 | 88.04 |
| 21 Jul 2026 | 89.23 |
| 20 Jul 2026 | 90.72 |
| 17 Jul 2026 | 87.05 |
| 16 Jul 2026 | 86.35 |
Historical Revenue of Bal Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Bal Pharma Ltd
Historical EBITDA of Bal Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Bal Pharma Ltd
Historical Net Profit of Bal Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Bal Pharma Ltd
Bal Pharma Ltd News Hub
Bal Pharma schedules AGM
Bal Pharma announced that the Annual General Meeting (AGM) of the company will be held on 25 Septemb
Read more
16 Aug 24
Bal Pharma consolidated net profit rises 225.00% in the June 2024 quarter
Net profit of Bal Pharma rose 225.00% to Rs 0.26 crore in the quarter ended June 2024 as against Rs
Read more
13 Aug 24
Bal Pharma to convene board meeting
Bal Pharma will hold a meeting of the Board of Directors of the Company on 9 September 2024. Powered
Read more
31 Aug 24
Bal Pharma schedules board meeting
Bal Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powered
Read more
06 Nov 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Bal Pharma Ltd
- Bal Pharma Limited (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May 1987.
- In March 1990, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
- The company promotes its products through the common sales force of the group but proposes to induct its own soon.
- It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.
FAQs for Quarterly Results of Bal Pharma Ltd
What key financial metrics are included in Bal Pharma Ltd's quarterly results?
When does Bal Pharma Ltd announce its quarterly results?
How does Bal Pharma Ltd's quarterly performance impact its stock price?
What is the impact of Bal Pharma Ltd's quarterly results on dividends?
Are there any special announcements usually made during Bal Pharma Ltd's quarterly results?
